Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07864142

First-Trimester Screening of Open Neural Tube Defects Using Biometrics and Maternal Serum Markers

Conditions: Neural Tube Defects (NTDs)

Sex: Female
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 100
Sponsor: University Hospital, Strasbourg, France

Location: Service de Gynécologie et Obstétrique - CHU de Strasbourg - France Strasbourg

Summary

Open neural tube defects are congenital malformations associated with significant morbidity. Early detection during the first trimester remains a key challenge. This retrospective monocentric study aims to evaluate the diagnostic performance of fetal biometrics (biparietal diameter and abdominal transverse diameter ratios) and maternal serum markers (beta-hCG and PAPP-A) for early screening of open neural tube defects. The study will assess the predictive value of these parameters individually and in combination to define optimal screening thresholds applicable in routine clinical practice

Eligibility Criteria

Inclusion Criteria: * Adult pregnant woman (≥18 years) * First-trimester ultrasound performed at Strasbourg University Hospitals between 01/01/2011 and 31/12/2023 * No written opposition to reuse of medical data for research purposes Exclusion Criteria: * Written opposition to reuse of medical data for research purposes * Multiple pregnancy * Presence of fetal growth abnormality, morphological or genetic anomaly during pregnancy * Crown-rump length \84 mm at screening ultrasound * Missing data * Fetus with closed dysraphism

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07864142). StuddyBuddy aggregates publicly available trial information.